Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-4254
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States ; day:8 ; month:9 ; year:2020 ; pages:1-12
PharmacoEconomics - open ; (8.9.2020), 1-12
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-020-00229-4
- URN
-
urn:nbn:de:101:1-2020102818004656564716
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elsaid, Mohamed I.
- Li, You
- Catalano, Carolyn
- Minacapelli, Carlos D.
- Gupta, Kapil
- Rustgi, Vinod K.
- SpringerLink (Online service)
Other Objects (12)
Care Among Migraine Patients in a Commercially Insured Population
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
Medical and financial burden of acute intermittent porphyria
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
Care Among Migraine Patients in a Commercially Insured Population
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
Medical and financial burden of acute intermittent porphyria
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
Care Among Migraine Patients in a Commercially Insured Population
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
Medical and financial burden of acute intermittent porphyria
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States